Assignee
CANCER TARGETED TECH LLC
US·4 granted patents·5 pending applications·5 citations·filing 2014–2025
Top patents by PatentIndex Score
9 records- 0184US9974869B2Chelated PSMA inhibitorsCANCER TARGETED TECH LLC·Filed 2016·Granted May 22, 2018·3 cites·10 claims
- 0279US11225496B2Chelated PSMA inhibitorsCANCER TARGETED TECH LLC·Filed 2017·Granted Jan 18, 2022·2 cites·14 claims
- 0376US2025375542A118f-labeled psma-targeted pet imaging agentsCANCER TARGETED TECH LLC·Filed 2025·Application pending·0 cites
- 0467US2023144322A118f-labeled psma-targeted pet imaging agentsCANCER TARGETED TECH LLC·Filed 2023·Application pending·0 cites
- 0560US2025242034A1Phosphoramidate-based psma-targeted small-molecule drug conjugatesCANCER TARGETED TECH LLC·Filed 2023·Application pending·0 cites
- 0659US11554183B218F-labeled PSMA-targeted PET imaging agentsCANCER TARGETED TECH LLC·Filed 2014·Granted Jan 17, 2023·0 cites·18 claims
- 0759US2022162241A1Chelated PSMA InhibitorsCANCER TARGETED TECH LLC·Filed 2021·Application pending·0 cites
- 0850US2023064292A1Methods of treating psma-positive cancer using radionuclide therapyCANCER TARGETED TECH LLC·Filed 2021·Application pending·0 cites
- 0943US11147889B2Albumin-binding PSMA inhibitorsCANCER TARGETED TECH LLC·Filed 2017·Granted Oct 19, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when CANCER TARGETED TECH LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →